Cite
Salla M, Butler MS, Pelingon R, et al. Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Med Chem Lett. 2016;7(12):1034-1038doi: 10.1021/acsmedchemlett.6b00198.
Salla, M., Butler, M. S., Pelingon, R., Kaeslin, G., Croker, D. E., Reid, J. C., Baek, J. M., Bernhardt, P. V., Gillam, E. M., Cooper, M. A., & Robertson, A. A. (2016). Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS medicinal chemistry letters, 7(12), 1034-1038. https://doi.org/10.1021/acsmedchemlett.6b00198
Salla, Manohar, et al. "Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950." ACS medicinal chemistry letters vol. 7,12 (2016): 1034-1038. doi: https://doi.org/10.1021/acsmedchemlett.6b00198
Salla M, Butler MS, Pelingon R, Kaeslin G, Croker DE, Reid JC, Baek JM, Bernhardt PV, Gillam EM, Cooper MA, Robertson AA. Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Med Chem Lett. 2016 Sep 27;7(12):1034-1038. doi: 10.1021/acsmedchemlett.6b00198. eCollection 2016 Dec 08. PMID: 27994733; PMCID: PMC5150672.
Copy
Download .nbib